Bentham Science Logo

Track Your Manuscript:

Current Pharmaceutical Design

Volume 28, 46 Issues, 2022
ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)
This journal supports open access


Current Pharmaceutical Design , Volume 20 - Number 2

Mitochondria-targeted Resveratrol Derivatives Act as Cytotoxic Pro-oxidants

, 20(2): 172 - 179

Nicola Sassi, Andrea Mattarei, Michele Azzolini, Paolo Bernardi, Ildiko' Szabo', Cristina Paradisi, Mario Zoratti and Lucia Biasutto

DOI: 10.2174/13816128113199990034

Mitochondrial Permeability Transition as Target of Anticancer Drugs

, 20(2): 223 - 244

Lisa Dalla Via, Aida N. Garcia-Argaez, Mariano Martinez-Vazquez, Silvia Grancara, Pamela Martinis and Antonio Toninello

DOI: 10.2174/13816128113199990033

Charge Deficient Analogues of the Natural Polyamines

, 20(2): 262 - 277

Janne Weisell, Mervi T. Hyvonen, Leena Alhonen, Jouko Vepsalainen, Tuomo A. Keinanen and Alex R. Khomutov

DOI: 10.2174/13816128113199990037

Hypusine Modification of the Ribosome-binding Protein eIF5A, a Target for New Anti-Inflammatory Drugs: Understanding the Action of the Inhibitor GC7 on a Murine Macrophage Cell Line

, 20(2): 284 - 292

Oedem Paulo de Almeida Jr, Thais Regina Toledo, Danuza Rossi, Daniella de Barros Rossetto, Tatiana Faria Watanabe, Fabio Carrilho Galvao, Alexandra Ivo Medeiros, Cleslei Fernando Zanelli and Sandro Roberto Valentini

DOI: 10.2174/13816128113199990036


Alessandro Antonelli
(14789 citations)
Department of Clinical and Experimental Medicine
Laboratory of Primary Human Cells
University of Pisa
View Full Editorial Board

Nobel Laureate on Editorial Board

Andrew V. Schally

COPE Compliant

Cope Logo



Related Journals

Related eBooks

eBooks Catalog